Related Experiment Video
Updated: Aug 14, 2026
08:24
A Hydrophobic Tissue Clearing Method for Rat Brain Tissue
Published on: December 23, 2020
Rodent model systems for studies of HIV-1 associated dementia
Y Persidsky1, R Potula, J Haorah
1Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198, USA. ypersids@unmc.edu
Neurotoxicity Research
|November 2, 2005
Summary
Developing effective treatments for HIV-1 neuropathogenesis necessitates accurate animal models. This review examines rodent models, including transgenic and SCID mice, to understand brain inflammation and guide therapy development for HIV-1 neurological impairment.
Area of Science:
- Neuroscience
- Immunology
- Virology
Background:
- HIV-1 infection can lead to significant neurological complications, known as HIV-1-associated neurocognitive disorders (HAND).
- Understanding the mechanisms of HIV-1 neuropathogenesis is crucial for developing effective treatments.
- Relevant and accurate animal models are essential for studying HIV-1 brain infection and testing therapeutic strategies.
Purpose of the Study:
- To review and discuss various rodent models used to study HIV-1 neuropathogenesis.
- To evaluate the utility and limitations of these models in reflecting human disease.
- To highlight the importance of these models for developing therapies against HIV-1-associated neurologic impairment.
Main Methods:
- Review of existing literature on animal models for HIV-1 neuropathogenesis.
- Categorization of models including transgenic rodents, murine retroviral infections, and humanized SCID mouse models.
- Discussion of the strengths and weaknesses of each model type.
Main Results:
- Several rodent models, including transgenic animals, murine retroviral infections, and humanized SCID mice, partially reflect HIV-1-induced neuroinflammation and neurotoxicity.
- Each model presents unique advantages and limitations in mimicking the complexity of human HIV-1 brain infection.
- These models provide valuable platforms for investigating disease mechanisms and evaluating potential therapeutic interventions.
Conclusions:
- Rodent models are indispensable tools for advancing the understanding of HIV-1 neuropathogenesis.
- Careful selection and interpretation of results from these models are necessary for successful therapeutic development.
- Continued refinement of animal models will accelerate the development of treatments for HAND.
